NOR-QD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nor-qd, and when can generic versions of Nor-qd launch?
Nor-qd is a drug marketed by Teva Branded Pharm and is included in one NDA.
The generic ingredient in NOR-QD is norethindrone. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the norethindrone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nor-qd
A generic version of NOR-QD was approved as norethindrone by GLENMARK PHARMS LTD on July 22nd, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NOR-QD?
- What are the global sales for NOR-QD?
- What is Average Wholesale Price for NOR-QD?
Summary for NOR-QD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Patent Applications: | 5,113 |
| Drug Prices: | Drug price information for NOR-QD |
| DailyMed Link: | NOR-QD at DailyMed |
US Patents and Regulatory Information for NOR-QD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | NOR-QD | norethindrone | TABLET;ORAL-28 | 017060-001 | Approved Prior to Jan 1, 1982 | AB1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
